Hepatitis C virus genotype 4-infection and interferon-free treatment in Egypt Tatsuo KandaShunichi MatsuokaMitsuhiko Moriyama Editorial 10 July 2018 Pages: 291 - 293
Depression, fatigue and neurocognitive deficits in chronic hepatitis C Sern Wei YeohAlex C. N. HolmesAmanda J. Nicoll Review Article 21 June 2018 Pages: 294 - 304
Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells Muhammad AtifSuz WarnerYe H. Oo Review Article Open access 19 July 2018 Pages: 305 - 314
Global HBV burden: guesstimates and facts Dina GinzbergRobert J. WongRobert Gish Review Article 27 July 2018 Pages: 315 - 329
Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis Seogsong JeongGuijuan LuoQiang Xia Original Article 26 June 2018 Pages: 330 - 338
Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience G. ShihaR. SolimanN. N. H. Mikhail Original Article 16 April 2018 Pages: 339 - 347
Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4 Adel Abdel-MoneimAlaa AboudMohamed Ramadan Original Article 12 May 2018 Pages: 348 - 355
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals Namiki IzumiTetsuo TakeharaMasashi Mizokami Original Article Open access 20 July 2018 Pages: 356 - 367
Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system Masashi KudoNaoto GotohdaRyuichi Hayashi Original Article Open access 02 June 2018 Pages: 368 - 376
Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis Rahima A. BhanjiCarlos Moctezuma-VelazquezAldo J. Montano-Loza Original Article 07 June 2018 Pages: 377 - 386